摘要
再灌注治疗(包括静脉溶栓和血管内治疗)是急性缺血性卒中的有效治疗方法。作为再灌注治疗后的常见并发症,出血性转化与患者转归不良密切相关。早期通过临床特征、影像学和血液生物标志物进行评估可预测出血性转化风险,从而更好地指导急性缺血性卒中患者的再灌注治疗。
Reperfusion therapy,including intravenous thrombolysis and endovascular therapy,is an effective treatment for acute ischemic stroke.As a common complication after reperfusion therapy,hemorrhagic transformation is closely associated with the poor outcomes of patients.Early evaluation of clinical features,imaging and blood biomarkers can predict the risk of hemorrhagic transformation,so as to better guide the reperfusion treatment in patients with acute ischemic stroke.
作者
刘茹慧
梁志刚
Liu Ruhui;Liang Zhigang(The Second Clinical Medical College of Binzhou Medical University,Yantai 264003,China;Department of Neurology,Yantai Yuhuangding Hospital Affiliated to Qingdao University,Yantai 264000,China)
出处
《国际脑血管病杂志》
2023年第1期48-53,共6页
International Journal of Cerebrovascular Diseases
基金
烟台市科技发展计划(2018SFGY092,2021YD033)。
关键词
卒中
脑缺血
血栓溶解疗法
血管内治疗
血栓切除术
颅内出血
危险因素
Stroke
Brain ischemia
Thrombolytic therapy
Endovascular procedures
Thrombectomy
Intracranial hemorrhages
Risk factors
